Loading clinical trials...

A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT02006667

A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer

This study will evaluate the efficacy and safety of a chemotherapy regimen of intravenous Herceptin, cisplatin and gemcitabine in patients with metastatic urothelial cancer. The anticipated time on st...

Lead sponsor: Hoffmann-La Roche•7 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 3

A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract

NCT02928406 · Urinary Tract Cancer

COMPLETEDPhase 1

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

NCT04430842 · Astrocytoma, Brain Cancer, and more

COMPLETED

CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma

NCT03013920 · Urinary Tract Cancer, Urothelial Carcinoma, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 11, 2015Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment13

Start dateJan 2001

Last updatedFeb 11, 2015

Condition

Urinary Tract Cancer

Locations shown

Aschersleben

Dessau

Fulda

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 11, 2015Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions